|4Dec 13, 5:24 PM ET

Casey Mark J 4

4 · NOVAVAX INC · Filed Dec 13, 2024

Insider Transaction Report

Form 4
Period: 2024-12-11
Casey Mark J
EVP, Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-12-11+41,90041,900 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-12-1141,90083,798 total
    Exercise: $0.00Exp: 2033-12-11Common Stock (41,900 underlying)
  • Tax Payment

    Common Stock

    2024-12-11$8.82/sh12,713$112,12929,187 total
Footnotes (1)
  • [F1]One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Documents

1 file
  • 4
    primary_01.xmlPrimary

    PRIMARY DOCUMENT